International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
A Novel Scheme for Optimal Control of a Nonlinear Delay Differential Equations Model to Determine Effective and Optimal Administrating Chemotherapy Agents in Breast Cancer
Abstract
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Clinical Outcome and Prognostic Factors in Iranian Breast Cancer Patients After Neoadjuvant Chemotherapy: A Comparative Matched Study
Yousefi Kashi AS, Montazeri R, Rakhsha A. Clinical Outcome and Prognostic Factors in Iranian Breast Cancer Patients After Neoadjuvant Chemotherapy: A Comparative Matched Study. Int J Cancer Manag. 2018;11(5):e67739. doi: https://doi.org/10.5812/ijcm.67739
Breast Tumor Response & Axillary Clearance After Neoadjuvant Chemotherapy
Bayat M, Hatami H, Akbari ME. Breast Tumor Response & Axillary Clearance After Neoadjuvant Chemotherapy. Int J Cancer Manag. 2026;19(1):e170019. doi: https://doi.org/10.5812/ijcm-170019
Factors Impacting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer: A Single-Center Study
Olfatbakhsh A, Tafazzoli-Harandi H, Najafi S, Hashemi EAS, Sari F, et al. Factors Impacting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer: A Single-Center Study. Int J Cancer Manag. 2018;11(5):e60098. doi: https://doi.org/10.5812/ijcm.60098
Economic Evaluation of Neoadjuvant Treatment Strategies for HER2 Positive Breast Cancer: A Systematic Review
Akbari M, Seyednezhad M, Heidari S, Moradi-joo M. Economic Evaluation of Neoadjuvant Treatment Strategies for HER2 Positive Breast Cancer: A Systematic Review. Int J Cancer Manag. 2023;16(1):e142814. doi: https://doi.org/10.5812/ijcm-142814
Pilot Study Comparing Epirubicin, Oxaliplatin, Capecitabine (EOX) and Docetaxel, Cisplatin, and 5-Fluorouracil (TCF) Regimens in Neoadjuvant Chemotherapy for Gastric Cancer Patients
Cheraghi M, Bahadoran E, Masoomi M, Mohammadi N. Pilot Study Comparing Epirubicin, Oxaliplatin, Capecitabine (EOX) and Docetaxel, Cisplatin, and 5-Fluorouracil (TCF) Regimens in Neoadjuvant Chemotherapy for Gastric Cancer Patients. J Inflamm Dis. 2024;28(4):e154396. doi: https://doi.org/10.69107/jid-154396
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 13
Last Update: 1 week ago
- Scopus by Title (Ref): 13
Last Update: 1 week ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):